Evaxion Biotech AS (EVAX) — Net Asset Momentum
Evaxion Biotech AS (EVAX) recorded a net asset momentum of 1131.4% as of December 2025, with net assets of $17.04 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is Evaxion Biotech AS's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Evaxion Biotech AS Net Asset Momentum (2017–2025)
This chart tracks Evaxion Biotech AS's year-over-year net asset growth across 9 annual reporting periods from 2017 to 2025. The most recent momentum reading is +1131.4%, with net assets of $17.04 Million USD as of December 2025. For live market cap and overall valuation, see EVAX stock market capitalisation.
Annual Net Asset History for Evaxion Biotech AS (2017–2025)
The table below shows the complete annual net asset history for Evaxion Biotech AS from 2017 to 2025, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Evaxion Biotech AS (EVAX) tangible net worth to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $17.04 Million | $28.41 Million | $11.37 Million | ▲ +1131.4% |
| 2024 | $-1.65 Million | $12.48 Million | $14.14 Million | ▲ +65.1% |
| 2023 | $-4.73 Million | $12.89 Million | $17.62 Million | ▼ -157.0% |
| 2022 | $8.30 Million | $22.02 Million | $13.72 Million | ▼ -74.4% |
| 2021 | $32.44 Million | $40.16 Million | $7.73 Million | ▲ +360.9% |
| 2020 | $7.04 Million | $11.96 Million | $4.93 Million | ▼ -24.8% |
| 2019 | $9.36 Million | $11.08 Million | $1.72 Million | ▲ +1105.6% |
| 2018 | $-931.00K | $8.51 Million | $9.44 Million | ▼ -136.5% |
| 2017 | $2.55 Million | $2.95 Million | $399.00K | — |